Drug Price Transparency RAC

The Oregon Prescription Drug Price Transparency (DPT) program was first enacted in 2018 (HB 4005) and was expanded in 2019 (HB 2658). The goal of the DPT program is to provide accountability for prescription drug pricing through the notice and disclosure of specific drug costs and price information from pharmaceutical manufacturers, health insurers, and consumers. With 5 years of implementation experience, program staff have identified common reporting errors that could be avoided with rulemaking changes. The proposed rule changes will improve the quality and timeliness of data collected as well as ease the administrative burden on both the DPT program and manufacturers.

Committee Contacts

Lily Sobolik
Senior Health Policy Advisor
lily.sobolik@dcbs.oregon.gov
Phone: 971-446-8813

Sofie Parra
DPT Program Coordinator
sofia.e.parra@dcbs.oregon.gov
Phone: 503-983-0447

Karen Winkel
Rules Coordinator
Karen.J.Winkel@dcbs.oregon.gov
Phone: 503-947-7694